255 related articles for article (PubMed ID: 31739483)
21. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.
Balashova NV; Park DH; Patel JK; Figurski DH; Kachlany SC
Infect Immun; 2007 Sep; 75(9):4490-7. PubMed ID: 17635874
[TBL] [Abstract][Full Text] [Related]
22. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
[TBL] [Abstract][Full Text] [Related]
23. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages.
Feldman M; Grenier D
J Appl Microbiol; 2012 Aug; 113(2):438-47. PubMed ID: 22563853
[TBL] [Abstract][Full Text] [Related]
24. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
[TBL] [Abstract][Full Text] [Related]
25. Cranberry proanthocyanidins inhibit MMP production and activity.
La VD; Howell AB; Grenier D
J Dent Res; 2009 Jul; 88(7):627-32. PubMed ID: 19641150
[TBL] [Abstract][Full Text] [Related]
26.
Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
[TBL] [Abstract][Full Text] [Related]
27. Receptor-Based Peptides for Inhibition of Leukotoxin Activity.
Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC
ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
29. The Extracellular Domain of the β
Ristow LC; Tran V; Schwartz KJ; Pankratz L; Mehle A; Sauer JD; Welch RA
mBio; 2019 Jul; 10(4):. PubMed ID: 31289186
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of Size and Toxin Distribution in
Nice JB; Collins SM; Agro SMJ; Sinani A; Moros SD; Pasch LM; Brown AC
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535804
[No Abstract] [Full Text] [Related]
31. Circulating antibodies against leukotoxin A as marker of periodontitis Grades B and C and oral infection with Aggregatibacter actinomycetemcomitans.
Damgaard C; Danielsen AK; Enevold C; Reinholdt J; Holmstrup P; Nielsen CH; Massarenti L
J Periodontol; 2021 Dec; 92(12):1795-1804. PubMed ID: 33749825
[TBL] [Abstract][Full Text] [Related]
32. Proanthocyanidins from the American Cranberry (Vaccinium macrocarpon) inhibit matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in human prostate cancer cells via alterations in multiple cellular signalling pathways.
Déziel BA; Patel K; Neto C; Gottschall-Pass K; Hurta RA
J Cell Biochem; 2010 Oct; 111(3):742-54. PubMed ID: 20626034
[TBL] [Abstract][Full Text] [Related]
33. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
34.
Kelk P; Moghbel NS; Hirschfeld J; Johansson A
Pathogens; 2022 Jan; 11(2):. PubMed ID: 35215102
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains.
Brogan JM; Lally ET; Poulsen K; Kilian M; Demuth DR
Infect Immun; 1994 Feb; 62(2):501-8. PubMed ID: 8300209
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory and macrophage polarization effects of Cranberry Proanthocyanidins (PACs) for periodontal and peri-implant disease therapy.
Galarraga-Vinueza ME; Dohle E; Ramanauskaite A; Al-Maawi S; Obreja K; Magini R; Sader R; Ghanaati S; Schwarz F
J Periodontal Res; 2020 Dec; 55(6):821-829. PubMed ID: 32557637
[TBL] [Abstract][Full Text] [Related]
37. Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Claesson R; Hänström L; Lerner UH; Kalfas S; Johansson A
Infect Immun; 2005 Jan; 73(1):453-8. PubMed ID: 15618184
[TBL] [Abstract][Full Text] [Related]
38. Cranberry proanthocyanidins: natural weapons against periodontal diseases.
Feghali K; Feldman M; La VD; Santos J; Grenier D
J Agric Food Chem; 2012 Jun; 60(23):5728-35. PubMed ID: 22082264
[TBL] [Abstract][Full Text] [Related]
39. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes.
Munksgaard PS; Vorup-Jensen T; Reinholdt J; Söderström CM; Poulsen K; Leipziger J; Praetorius HA; Skals M
Cell Microbiol; 2012 Dec; 14(12):1904-20. PubMed ID: 22906303
[TBL] [Abstract][Full Text] [Related]
40. Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.
Li Z; Baidoun R; Brown AC
Colloids Surf B Biointerfaces; 2024 Jun; 238():113870. PubMed ID: 38555763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
